Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1987 1
1988 1
1989 2
1990 1
1993 4
1994 2
1995 2
1996 1
1997 1
1998 2
2000 1
2001 1
2002 2
2003 1
2004 3
2005 7
2006 2
2007 3
2008 6
2009 7
2010 8
2011 8
2012 12
2013 13
2014 10
2015 10
2016 16
2017 9
2018 17
2019 18
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Results by year
Filters applied: . Clear all
Page 1
Testosterone and the Heart.
Goodale T, Sadhu A, Petak S, Robbins R. Goodale T, et al. Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):68-72. doi: 10.14797/mdcj-13-2-68. Methodist Debakey Cardiovasc J. 2017. PMID: 28740585 Free PMC article. Review.
Testosterone (T) has a number of important effects on the cardiovascular system. In men, T levels begin to decrease after age 40, and this decrease has been associated with an increase in all-cause mortality and cardiovascular (CV) risk. ...Testoste
Testosterone (T) has a number of important effects on the cardiovascular system. In men, T levels begin to decrease aft
Testosterone and the Heart.
Kirby M, Hackett G, Ramachandran S. Kirby M, et al. Eur Cardiol. 2019 Jul 11;14(2):103-110. doi: 10.15420/ecr.2019.13.1. eCollection 2019 Jul. Eur Cardiol. 2019. PMID: 31360231 Free PMC article. Review.
The development of a subnormal level of testosterone (T) is not universal in ageing men, with 75% of men retaining normal levels. However, a substantial number of men do develop T deficiency (TD), with many of them carrying a portfolio of cardiovascular (CV) risk fa …
The development of a subnormal level of testosterone (T) is not universal in ageing men, with 75% of men retaining normal levels. How …
Male hypogonadism.
Basaria S. Basaria S. Lancet. 2014 Apr 5;383(9924):1250-63. doi: 10.1016/S0140-6736(13)61126-5. Epub 2013 Oct 10. Lancet. 2014. PMID: 24119423 Review.
Several testosterone-replacement therapies are approved for treatment and should be selected according to the patient's preference, cost, availability, and formulation-specific properties. Contraindications to testosterone-replacement therapy include prostate …
Several testosterone-replacement therapies are approved for treatment and should be selected according to the patient's prefer …
Testosterone and the heart.
Hackett G. Hackett G. Int J Clin Pract. 2012 Jul;66(7):648-55. doi: 10.1111/j.1742-1241.2012.02922.x. Int J Clin Pract. 2012. PMID: 22698417
Several large scale studies in recent years have demonstrated increased cardiovascular mortality in men with low testosterone, especially those with existing cardiovascular disease and type 2 diabetes. ...There is early evidence from non-randomised stu …
Several large scale studies in recent years have demonstrated increased cardiovascular mortality in men with low testosterone, …
Lessons From the Testosterone Trials.
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Resnick SM, Budoff M, Mohler ER 3rd, Wenger NK, Cohen HJ, Schrier S, Keaveny TM, Kopperdahl D, Lee D, Cifelli D, Ellenberg SS. Snyder PJ, et al. Endocr Rev. 2018 Jun 1;39(3):369-386. doi: 10.1210/er.2017-00234. Endocr Rev. 2018. PMID: 29522088 Free PMC article.
In the Bone Trial, testosterone increased volumetric bone mineral density and the estimated strength of the spine and hip. In the Cardiovascular Trial, testosterone increased the coronary artery noncalcified plaque volume as assessed using computed tomographi …
In the Bone Trial, testosterone increased volumetric bone mineral density and the estimated strength of the spine and hip. In the …
Testosterone and cardiovascular risk in men.
Kelly DM, Jones TH. Kelly DM, et al. Front Horm Res. 2014;43:1-20. doi: 10.1159/000360553. Epub 2014 Jun 10. Front Horm Res. 2014. PMID: 24943294 Review.
Testosterone deficiency is highly prevalent in men with cardiovascular disease (CVD) and is associated with an increased mortality. Low testosterone also has an adverse effect on several cardiovascular risk factors, which include insulin resistance,
Testosterone deficiency is highly prevalent in men with cardiovascular disease (CVD) and is associated with an increased morta
Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
Jones TH, Kelly DM. Jones TH, et al. Asian J Androl. 2018 Mar-Apr;20(2):120-130. doi: 10.4103/aja.aja_6_18. Asian J Androl. 2018. PMID: 29442075 Free PMC article. Review.
Testosterone deficiency is common in men with cardiovascular disease (CVD), and randomized placebo-controlled trials (RCTs) have reported beneficial effects of testosterone therapy on exercise-induced cardiac ischemia in chronic stable angina, functional exer
Testosterone deficiency is common in men with cardiovascular disease (CVD), and randomized placebo-controlled trials (RCTs) ha
Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis.
Elliott J, Kelly SE, Millar AC, Peterson J, Chen L, Johnston A, Kotb A, Skidmore B, Bai Z, Mamdani M, Wells GA. Elliott J, et al. BMJ Open. 2017 Nov 16;7(11):e015284. doi: 10.1136/bmjopen-2016-015284. BMJ Open. 2017. PMID: 29150464 Free PMC article. Review.
Outcomes were quality of life, depression, libido, erectile function, activities of daily living and testosterone levels, as well as cardiovascular death, myocardial infarction, stroke, prostate cancer, heart disease, diabetes, serious adverse events, …
Outcomes were quality of life, depression, libido, erectile function, activities of daily living and testosterone levels, as well as …
Voluntary wheel running and testosterone replacement increases heart angiogenesis through miR-132 in castrated diabetic rats.
Chodari L, Dariushnejad H, Ghorbanzadeh V. Chodari L, et al. Physiol Int. 2019 Mar 1;106(1):48-58. doi: 10.1556/2060.106.2019.06. Epub 2019 Mar 25. Physiol Int. 2019. PMID: 30907089
OBJECTIVE: Low levels of testosterone in men with diabetes are associated with cardiovascular complications. We investigated the effect of testosterone and voluntary exercise on heart angiogenesis in castrated diabetic rats. ...Testost
OBJECTIVE: Low levels of testosterone in men with diabetes are associated with cardiovascular complications. We investi …
Type 2 Diabetes and Testosterone Therapy.
Hackett G. Hackett G. World J Mens Health. 2019 Jan;37(1):31-44. doi: 10.5534/wjmh.180027. Epub 2018 Jul 17. World J Mens Health. 2019. PMID: 30079639 Free PMC article. Review.
A third of men with type 2 diabetes (T2DM) have hypogonadotrophic hypogonadism (HH) and associated increased risk of cardiovascular and all-cause mortality. ...We conducted MEDLINE, EMBASE, and COCHRANE reviews on T2DM, HH, testosterone deficiency, cardiov
A third of men with type 2 diabetes (T2DM) have hypogonadotrophic hypogonadism (HH) and associated increased risk of cardiovascula
159 results
Jump to page
Feedback